Connect

Member Research and Reports

Member Research and Reports

Harvard Finds Boosting Vitamin D Could Reduce Severity of Multiple Sclerosis

For patients in the early stages of multiple sclerosis (MS), low levels of vitamin D were found to strongly predict disease severity and hasten its progression, according to a new study led by Harvard School of Public Health investigators in collaboration with Bayer HealthCare. The findings suggest that patients in the early stages of MS could stave off disease symptoms by increasing their vitamin D intake. “Because low vitamin D levels are common and can be easily and safely increased by oral supplementation, these findings may contribute to better outcomes for many MS patients,” said lead author Dr. Alberto Ascherio, professor of epidemiology and nutrition. The study will appear online in JAMA Neurology.